Stockreport

ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases [Yahoo! Finance]

I-MAB - American Depositary Shares  (IMAB) 
PDF - Programs will leverage ABL Bio's Grabody-B platform technology to effectively deliver molecules a cross the blood-brain barrier - ABL Bio to receive up to £77 milli [Read more]